IRIS Accounts Production v24.2.0.383 07334494 director 1.1.23 31.12.23 31.12.23 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh073344942022-12-31073344942023-12-31073344942023-01-012023-12-31073344942021-12-31073344942022-01-012022-12-31073344942022-12-3107334494ns15:EnglandWales2023-01-012023-12-3107334494ns14:PoundSterling2023-01-012023-12-3107334494ns10:Director12023-01-012023-12-3107334494ns10:PrivateLimitedCompanyLtd2023-01-012023-12-3107334494ns10:SmallEntities2023-01-012023-12-3107334494ns10:AuditExempt-NoAccountantsReport2023-01-012023-12-3107334494ns10:SmallCompaniesRegimeForDirectorsReport2023-01-012023-12-3107334494ns10:SmallCompaniesRegimeForAccounts2023-01-012023-12-3107334494ns10:FullAccounts2023-01-012023-12-3107334494ns10:RegisteredOffice2023-01-012023-12-3107334494ns5:CurrentFinancialInstruments2023-12-3107334494ns5:CurrentFinancialInstruments2022-12-3107334494ns5:ShareCapital2023-12-3107334494ns5:ShareCapital2022-12-3107334494ns5:RetainedEarningsAccumulatedLosses2023-12-3107334494ns5:RetainedEarningsAccumulatedLosses2022-12-3107334494ns5:FurnitureFittings2023-01-012023-12-3107334494ns5:ComputerEquipment2023-01-012023-12-3107334494ns5:FurnitureFittings2022-12-3107334494ns5:ComputerEquipment2022-12-3107334494ns5:FurnitureFittings2023-12-3107334494ns5:ComputerEquipment2023-12-3107334494ns5:FurnitureFittings2022-12-3107334494ns5:ComputerEquipment2022-12-31073344941ns10:Director12022-12-31073344941ns10:Director12021-12-31073344941ns10:Director12023-01-012023-12-31073344941ns10:Director12022-01-012022-12-31073344941ns10:Director12023-12-31073344941ns10:Director12022-12-31
REGISTERED NUMBER: 07334494 (England and Wales)















Unaudited Financial Statements for the Year Ended 31 December 2023

for

Leo Medica Limited
Trading as
Beaudocs

Leo Medica Limited (Registered number: 07334494)
Trading as Beaudocs






Contents of the Financial Statements
for the Year Ended 31 December 2023




Page

Company Information 1

Statement of Financial Position 2

Notes to the Financial Statements 3


Leo Medica Limited
Trading as Beaudocs

Company Information
for the Year Ended 31 December 2023







DIRECTOR: Dr S Singh





REGISTERED OFFICE: The Brentano Suite
Solar House
915 High Road
London
N12 8QJ





REGISTERED NUMBER: 07334494 (England and Wales)





ACCOUNTANTS: Pi Accountants
Chartered Certified Accountants
The Brentano Suite
Solar House
915 High Road
London
N12 8QJ

Leo Medica Limited (Registered number: 07334494)
Trading as Beaudocs

Statement of Financial Position
31 December 2023

31/12/23 31/12/22
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 388 518

CURRENT ASSETS
Prepayments and accrued income 505 502
Cash at bank 20,371 52,496
20,876 52,998
CREDITORS
Amounts falling due within one year 5 27,864 64,486
NET CURRENT LIABILITIES (6,988 ) (11,488 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

(6,600

)

(10,970

)

PROVISIONS FOR LIABILITIES 63 81
NET LIABILITIES (6,663 ) (11,051 )

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings (6,763 ) (11,151 )
SHAREHOLDERS' FUNDS (6,663 ) (11,051 )

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2023 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 18 September 2024 and were signed by:





Dr S Singh - Director


Leo Medica Limited (Registered number: 07334494)
Trading as Beaudocs

Notes to the Financial Statements
for the Year Ended 31 December 2023

1. STATUTORY INFORMATION

Leo Medica Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Fixtures and fittings - 25% on reducing balance
Computer equipment - 25% on reducing balance

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2022 - 1 ) .

Leo Medica Limited (Registered number: 07334494)
Trading as Beaudocs

Notes to the Financial Statements - continued
for the Year Ended 31 December 2023

4. TANGIBLE FIXED ASSETS
Fixtures
and Computer
fittings equipment Totals
£    £    £   
COST
At 1 January 2023
and 31 December 2023 195 1,851 2,046
DEPRECIATION
At 1 January 2023 175 1,353 1,528
Charge for year 5 125 130
At 31 December 2023 180 1,478 1,658
NET BOOK VALUE
At 31 December 2023 15 373 388
At 31 December 2022 20 498 518

5. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31/12/23 31/12/22
£    £   
Trade creditors 507 -
Other creditors 27,357 64,486
27,864 64,486

6. DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 31 December 2023 and 31 December 2022:

31/12/23 31/12/22
£    £   
Dr S Singh
Balance outstanding at start of year (62,110 ) (67,307 )
Amounts repaid 37,147 5,197
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year (24,963 ) (62,110 )

7. GOING CONCERN

The director believes the company will increase profitability in the future. The director will continue to support the company.